Files
Abstract
There is widespread evidence that the
use of somatotropin or growth hormone to improve
milk and pork production is safe.
An independent committee appointed by The
National Institutes of Health concluded that,
"The evidence clearly indicates that the overall
composition and nutritional quality of milk and
meat from bST-treated cows is equal to that
from untreated cows." Similarly, the FDA has
concluded that the use of bST presents no
increased health risk to consumers. In addition,
there is compelling evidence to indicate that
somatotropin poses no increased health risk
to the ta rget animal. Thus, treatment of farm
animals with somatotropin is not only an
effective technology for increasing productive
efficiency but one that poses no increased
health risk for either the consumer or the
target animal.